| Matriscino Associates,inc. | |
|
2300 Palm Beach Lakes Blvd Ste 210 West Palm Beach FL 33409-3304 | |
| (561) 832-7007 | |
| Not Available |
| Full Name | Matriscino Associates,inc. |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 2300 Palm Beach Lakes Blvd Ste 210, West Palm Beach, Florida |
| Authorized Official Name and Position | Dion Matriscino (PRESIDENT) |
| Authorized Official Contact | 5618327007 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Matriscino Associates,inc. 2300 Palm Beach Lakes Blvd Ste 210 West Palm Beach FL 33409-3304 Ph: () - | Matriscino Associates,inc. 2300 Palm Beach Lakes Blvd Ste 210 West Palm Beach FL 33409-3304 Ph: (561) 832-7007 |
| NPI Number | 1326381070 |
|---|---|
| Provider Enumeration Date | 04/01/2013 |
| Last Update Date | 01/19/2023 |
| Certification Date | 01/19/2023 |
| Medicare PECOS PAC ID | 4981844214 |
|---|---|
| Medicare Enrollment ID | O20130710000713 |
News Archive
Takeda Pharmaceutical Company Limited and Natrogen Therapeutics International, Inc. jointly announced today an agreement whereby Takeda will acquire an exclusive license to develop Natrogen's Natura-alpha compound as well as an option to acquire Natrogen. Natura-alpha is a synthetic small molecule oral compound that is believed to inhibit pro-inflammatory cytokine expression, which may help to reduce gastrointestinal inflammation. Natura-alpha is currently in Phase 2 development for the treatment of ulcerative colitis.
A recent study by researchers in California and published on the preprint server bioRxiv* in June 2020 shows that advancing age is associated with increased expression of pattern recognition receptor (PRR) genes and ACE2 receptors, possibly accounting in part for the increased severity of the disease in older adults.
A new study from the Icahn School of Medicine at Mount Sinai provides important insights into how the body regulates its production of heat, a process known as thermogenesis that is currently intensely studied as a target of diabetes and obesity treatment in humans.
A significant update to the PROGRESS-CTO (PROspective Global Registry for the Study of Chronic Total Occlusion Intervention) International Registry was presented today as late-breaking clinical science at Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions 2018.
New insights into how human cytomegalovirus, the leading cause of birth defects associated with infection spreads from pregnant mother to fetus and from organ to organ in newborns provides translational researchers an exciting new avenue for investigation that may lead to the development of therapeutic interventions.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326381070 | NPI | - | NPPES |
| 677834800 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | P97000056660 (Florida) | Primary |
| Provider Name | Dion V Matriscino |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1033414545 PECOS PAC ID: 8628217015 Enrollment ID: I20130614000478 |
News Archive
Takeda Pharmaceutical Company Limited and Natrogen Therapeutics International, Inc. jointly announced today an agreement whereby Takeda will acquire an exclusive license to develop Natrogen's Natura-alpha compound as well as an option to acquire Natrogen. Natura-alpha is a synthetic small molecule oral compound that is believed to inhibit pro-inflammatory cytokine expression, which may help to reduce gastrointestinal inflammation. Natura-alpha is currently in Phase 2 development for the treatment of ulcerative colitis.
A recent study by researchers in California and published on the preprint server bioRxiv* in June 2020 shows that advancing age is associated with increased expression of pattern recognition receptor (PRR) genes and ACE2 receptors, possibly accounting in part for the increased severity of the disease in older adults.
A new study from the Icahn School of Medicine at Mount Sinai provides important insights into how the body regulates its production of heat, a process known as thermogenesis that is currently intensely studied as a target of diabetes and obesity treatment in humans.
A significant update to the PROGRESS-CTO (PROspective Global Registry for the Study of Chronic Total Occlusion Intervention) International Registry was presented today as late-breaking clinical science at Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions 2018.
New insights into how human cytomegalovirus, the leading cause of birth defects associated with infection spreads from pregnant mother to fetus and from organ to organ in newborns provides translational researchers an exciting new avenue for investigation that may lead to the development of therapeutic interventions.
› Verified 8 days ago
News Archive
Takeda Pharmaceutical Company Limited and Natrogen Therapeutics International, Inc. jointly announced today an agreement whereby Takeda will acquire an exclusive license to develop Natrogen's Natura-alpha compound as well as an option to acquire Natrogen. Natura-alpha is a synthetic small molecule oral compound that is believed to inhibit pro-inflammatory cytokine expression, which may help to reduce gastrointestinal inflammation. Natura-alpha is currently in Phase 2 development for the treatment of ulcerative colitis.
A recent study by researchers in California and published on the preprint server bioRxiv* in June 2020 shows that advancing age is associated with increased expression of pattern recognition receptor (PRR) genes and ACE2 receptors, possibly accounting in part for the increased severity of the disease in older adults.
A new study from the Icahn School of Medicine at Mount Sinai provides important insights into how the body regulates its production of heat, a process known as thermogenesis that is currently intensely studied as a target of diabetes and obesity treatment in humans.
A significant update to the PROGRESS-CTO (PROspective Global Registry for the Study of Chronic Total Occlusion Intervention) International Registry was presented today as late-breaking clinical science at Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions 2018.
New insights into how human cytomegalovirus, the leading cause of birth defects associated with infection spreads from pregnant mother to fetus and from organ to organ in newborns provides translational researchers an exciting new avenue for investigation that may lead to the development of therapeutic interventions.
› Verified 8 days ago
Rehab South Florida Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4460 Medical Center Way, West Palm Beach, FL 33407 Phone: 863-532-3151 | |
Salonia Psychotherapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1825 Forest Hill Blvd., #105, West Palm Beach, FL 33406 Phone: 954-650-6907 | |
Sunshine Of Tomorrow Behavioral Care Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7711 N Military Trl Ste 204, West Palm Beach, FL 33410 Phone: 561-914-4104 | |
Diosark, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1546 42nd St, West Palm Beach, FL 33407 Phone: 561-840-1647 Fax: 561-840-6415 | |
Crossroads Counseling Center Of The Palm Beaches Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1825 Forest Hill Blvd, Suite 105, West Palm Beach, FL 33406 Phone: 561-722-7084 Fax: 561-697-9925 | |
Wellbeing Therapy Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7750 Okeechobee Blvd # 4-76, West Palm Beach, FL 33411 Phone: 772-678-0341 | |
Be Free Stay Free Family & Individual Therapy Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3626 Whitehall Dr Apt 206, West Palm Beach, FL 33401 Phone: 561-377-2373 |